Table 1 Information on patients affected by various forms of epilepsy whose brain specimens were used for the experiments (ICC = Immunocytochemistry and Immunohistochemistry, TOX = Phenytoin toxicity, UP = drug uptake).
From: Significance of MDR1 and multiple drug resistance in refractory human epileptic brain
ID # | Sex | Age (years) | Use | Pathology |
|---|---|---|---|---|
1 | M | 8 months | ICC | Parieto-Occipital-Frontal cortical dysplasia, Right Hemispherectomy |
2 | F | 49 | ICC | Temporal Lobe Epilepsy, Hippocampal atrophy |
3 | F | 10 | ICC | Left Hippocampal sclerosis |
4 | F | 3 | ICC | Cortical Dysplasia, Right Hemispherectomy |
5 | M | 7 | ICC | Left Cortical Dysplasia |
6 | F | 4 | ICC | Right Frontoparietal Epilepsy |
7 | M | 1 | ICC | Left Frontal Lobe Epilepsy |
8 | M | 25 | ICC | Right Temporal Lobe Epilepsy |
9 | M | 45 | TOX, ICC | Temporal Lobe Epilepsy |
10 | F | 4 | TOX, ICC | Cortical Dysplasia |
11 | F | 36 | TOX, ICC | Temporal Lobe Epilepsy |
12 | M | 24 | UP | Left Frontal Lobe Epilepsy |
13 | F | 14 | UP | Cortical Dysplasia |
14 | M | 7 | UP | Left Temporal/Frontoparietal Epilepsy |